A lot of promises are made by organizations about making systems more intuitive, convenient and user-centric, but in reality most improvements tend to be designed to meet regulatory or internal system needs rather than better serve the people who use them. The user experience needs to be modernized, especially in heavily regulated industries where inaccurate or non-compliant labeling is laden with risk.
A discussion of the changing medtech markets and how companies can remain cognizant of potentially disruptive changes in their business and industry for future success in their product portfolios, services and relationships.
The outlook for 2020 and beyond is positive, but medical device companies must continue to evolve their technologies and partnerships to keep the attention of investors.
The hot issues are related to compliance, EU MDR and recalls.
Peter Micca of Deloitte discusses the changes that are happening within the healthcare ecosystem as a whole.
The transition to digital in healthcare is happening at a fast pace.
Medtech decision makers must accurately predict future trends in order to chart the best future directions and identify the most advantageous areas for business investment.
Topics from regenerative medicine to artificial intelligence to cannabis will be discussed.
A recent project conducted by Northeastern graduate students looked at device recalls over the past five years and some of the common threads.
Despite pricing pressures, several sectors within the medical device industry can expect to enjoy growth and attract attention from investors.
